Broncofin Liquid
Product Images NDC 53145-026

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Broncofin (NDC 53145-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Menper Distributors, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Broncofin (Broncofin)

Broncofin (Broncofin)
This is a drug information document for a cough suppressant containing Dextromethorphan HBr and a nasal decongestant containing Phenylephrine HCI. It is intended to provide relief from cough due to throat and bronchial irritation and nasal congestion resulting from common cold or inhaled irritants. It is important not to exceed the recommended dosage, and persistent cough may be a sign of a serious condition. This product should not be used for chronic cough accompanying smoking, asthma, chronic bronchitis or emphysema, or cough accompanied by excessive phlegm (mucus), unless directed by a doctor. It also contains a warning regarding the use of monoamine oxidase inhibitors (MAOI). Adult dosage and inactive ingredients are provided, and the product is not recommended for children under 12 years of age.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.